IL6 and inflammatory breast carcinoma: In primary IBC tumor specimens and corresponding cell lines excessive IL-6 expression is a recurring feature [24,27,28], which correlates with positivity for the activated and phosphorylated forms of JAK2 (pJAK2) and STAT3 (pSTAT3) [24].